Navigation Links
Cambridge Major Appoints Professor John Hartwig as Scientific Advisor
Date:10/31/2007

Expertise in Catalysis and Chiral Chemistry Adds to CML's Technical

Excellence

GERMANTOWN, Wis., Oct. 31 /PRNewswire/ -- Cambridge Major Laboratories announces the appointment of University of Illinois Professor John Hartwig as Scientific Advisor. Professor Hartwig is a world renowned expert in the application of catalysis to the synthesis of amines, halogens, and a variety of chiral transformations. His knowledge will play a vital role in advancing Cambridge Major's development of variety of chemical intermediates and Active Pharmaceutical Ingredients. He joins other prominent academics as part of CML's growing International Scientific Advisory Team.

Professor Hartwig's group has developed a series of catalytic reactions for organic synthesis, including palladium-catalyzed aminations of haloarenes, palladium-catalyzed alpha-arylation of carbonyl compounds, hydroaminations of vinylarenes and dienes, iridium-catalyzed enantioselective allylations of amines and alcohols, and the terminal functionalizations of alkanes. In addition, his group has uncovered new elementary organometallic reactions, such as reductive eliminations of amines, ethers and sulfides, insertions of olefins into transition metal amides and alkoxides, and the oxidative addition of ammonia.

John F. Hartwig received his A.B. from Princeton in 1986 and his Ph.D. from the University of California, Berkeley in 1990. Subsequently, he was an American Cancer Society Postdoctoral Fellow at the Massachusetts Institute of Technology and joined Yale University in 1992 where he was awarded the Irenee P. duPont Professorship in Chemistry in 2004. Dr. Hartwig joined the University of Illinois chemistry faculty in 2006 and currently holds the Kenneth J. Rinehart Jr. Professorship. John Hartwig has received numerous awards including an A.C. Cope Scholar (1998) Award, the Leo Hendrik Baekeland (2003) Award, the Thieme-IUPAC Prize in Synthetic Organic Chemistry (2004), the ACS Award in Organometallic Chemistry (2006), and the Tetrahedron Young Investigator Award in Organic Synthesis (2007).

"It has been a pleasure to become part of the synthetic chemistry community in the midwest, and I am looking forward to working with the experienced and skilled group of synthetic chemists at Cambridge Major Laboratories," said John Hartwig, Kenneth L. Rinehart Jr. Professor of Chemistry, University of Illinois.

"We are excited to have Professor Hartwig join our Scientific Advisory Team. His expertise will significantly help us to expedite synthesis of a wide range of pharmacologically active substances and their key intermediates," said Dr. Michael Major, President and CEO of Cambridge Major. "The addition of Professor Hartwig underscores our commitment to scientific excellence, and also our desire to provide our customers innovative and highly relevant chemistry that works."

Cambridge Major Laboratories, Inc. is a service-based chemistry outsourcing partner to the world's leading pharmaceutical and biotechnology companies, producing pharmaceutical intermediates, Active Pharmaceutical Ingredients, and other organic chemicals. Specializing in chemical process development and advanced multi-step organic synthesis, the Company operates two facilities near Milwaukee, Wisconsin including process chemistry laboratories, kilo labs, pilot plants, and complete analytical laboratories. The Company has been FDA inspected and approved for cGMP manufacturing. Visit us at http://www.c-mlabs.com


'/>"/>
SOURCE Cambridge Major Laboratories
Copyright©2007 PR Newswire.
All rights reserved

Related biology technology :

1. Determination of Acepromazine and its Major Metabolite in Equine Serum by LC-MS/MS using the Finnigan LCQ Deca XP Plus Ion Trap Mass Spectrometer
2. Wisconsin building toward the major leagues of venture capital
3. Six things to consider before a major software implementation
4. New company eyes major ethanol production facility
5. Boston equity firm becomes majority owner of Cedarburg-based Mortgagebot
6. University of Michigan plans major stem cell research center
7. BellBrook Labs gets major research funding
8. API announces major healthcare contracts
9. Top 20 big pharmas represent majority of world pharma market
10. Researchers report major advance in gene therapy technique
11. Sharon Ethanol appoints operations director
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Md. and GAITHERSBURG, Md. ... (NYSE MKT: PIP) and Altimmune, Inc., a privately-held ... signing of a definitive agreement for the merger ... Altimmune,s current investors include Novartis Venture Fund, HealthCap, ... will be a fully-integrated and diversified immunotherapeutics company ...
(Date:1/19/2017)... ... January 18, 2017 , ... ... and scientists from around the world, was today awarded the "Best Science & ... based entirely on merit and decided upon by a dedicated team of researchers ...
(Date:1/19/2017)... Md. , Jan. 18, 2017  Northwest Biotherapeutics, ... developing DCVax® personalized immune therapies for operable and inoperable ... Bosch , Chief Technical Officer of NW Bio, will ... January 19, 2017, at the Hyatt Regency Hotel in ... Bosch will chair the session entitled "New Therapeutic Approaches ...
(Date:1/18/2017)... -- According to a new market research report "In situ Hybridization ... End User (Molecular Diagnostic Laboratories, Academic and Research Institutions) - Global Forecast to ... by 2021 from USD 557.1 Million in 2016, growing at a CAGR of ... ... MarketsandMarkets Logo ...
Breaking Biology Technology:
(Date:1/19/2017)... , Jan. 19, 2017 ... user experience and security for consumer electronics, and ... payment processing systems and cybersecurity solutions, today announced ... enterprises and financial institutions worldwide to bolster security ... the end-to-end secure user authentication platforms they offer, ...
(Date:1/12/2017)... 12, 2017  Trovagene, Inc. (NASDAQ: TROV ... today announced that it has signed agreements with seven ... the Middle East for commercialization ... the first wave of international distribution agreements for Trovagene,s ... samples. The initial partners will introduce Trovagene,s ...
(Date:1/11/2017)... Johnson, co-founder of Visikol Inc. a company originally funded with an ... the elite "Forbes 30 Under 30" list in the Science category. ... fields nationwide to be recognized as a leader in business and ... ... PhD candidate at Rutgers University. Visikol , ...
Breaking Biology News(10 mins):